IPO Issue Details
Issue Price / Price Band₹130 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size115 Shares per Lot
Total Issue Size4,61,53,846 shares (aggregating up to ₹600.00 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 15 Mar 2021
Subscription CloseWed, 17 Mar 2021
Anchor AllotmentFri, 12 Mar 2021
Basis of AllotmentMon, 22 Mar 2021
Initiation of RefundsTue, 23 Mar 2021
Credit of Shares to DematWed, 24 Mar 2021
Listing DateThu, 25 Mar 2021
UPI Mandate Deadline2021-03-17
Application & Investment Details
Retail — Min (1 Lots)₹14,950 — 115 shares
Retail — Max (13 Lots)₹194,350 (13 Lots)
HNI — Min (14 Lots)₹2,09,300 — 1,610 shares
Pre-IPO Promoter Holding24,05,85,850 shares
Post-IPO Promoter Holding26,36,62,773 shares
Fresh Issue Shares2,30,76,923 shares (aggregating up to ₹300.00 Cr)
Offer for Sale Shares2,30,76,923 shares of ₹2 (aggregating up to ₹300.00 Cr)
About Laxmi Organic Industries Ltd.
Incorporated in 1989, Laxmi Organic Industries Ltd is a specialty chemical manufacturer that operates in 2 business segments; Acetyl Intermediates (AI) and Specialty Intermediates (SI). It is the leading manufacturer of ethyl acetate with over 30% market share in the Indian ethyl acetate market and the only manufacturer of diketene derivatives in India.Its AI segment includes ethyl acetate, acetaldehyde, fuel-grade ethanol, and other proprietary solvents whereas the SI segment includes ketene, diketene derivatives namely esters, acetic anhydride, arylides, amides, and other chemicals. Its products are being used in various industries like pharmaceuticals, agrochemicals, inks & coatings, dyes & pigments, paints, printing & packaging, etc. Alembic Pharmaceuticals Limited, Laurus Labs Limited, Granules India Limited, Hetero Labs Limited, Heubach Colour Private Limited, Hubergroup India Private Limited, Huhtamaki India Limited, Macleods Pharmaceuticals Private Limited, Suven Pharmaceuticals Limited, Colourtex Industries Private Limited, and UPL Limited are some of its customers.The company has a global footprint with customers in 30 countries including but not restricted to China, Russia, Singapore, UAE, UK, USA, Netherland, etc. Currently, it has 2 manufacturing facilities in Mahad, Maharashtra for the manufacturing of AI and SI products. It is also proposing to set-up a new manufacturing facility at Lote Parshuram, Maharashtra to manufacture four specialty chemicals.Competitive StrengthsLeading manufacturer of ethyl acetate in India.Largest manufacturer of diketene derivative products.Diversified customer base across industries.Strategically located manufacturing facilities.Consistent financial performance.
Objects of the Issue
Laxmi Organic Industries Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Investment in YFCPL for part-financing itscapital expenditure requirements in relation to the setting up of the Proposed Facility
60.40
2
2 Investment in YFCPL for funding its working capital requirements of YFCPL
37.74
3
3 Funding capital expenditure requirements for expansion of our SI Manufacturing Facility
91.06
4
4 Funding working capital requirements of our Company
35.18
5
5 Purchase of plant and machinery for augmenting infrastructure development at our SI Manufacturing Facility
12.57
6
6 Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company and VLPL
179.31
7
7 General corporate purposes
63.73
Shareholding & Lock-in
Pre-IPO Promoter Holding
24,05,85,850 shares
Post-IPO Promoter Holding
26,36,62,773 shares
Lock-in Period (30%)April 21, 2021
Lock-in Period (50%)June 20, 2021